PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: MISCELLANEOUS TUMORS.
D000230:Adenocarcinoma; D000970:Antineoplastic Agents; D006528:Carcinoma, Hepatocellular; D002294:Carcinoma, Squamous Cell; D002295:Carcinoma, Transitional Cell; D004358:Drug Therapy; D006918:Hydroxyurea; D007970:Leukopenia; D008113:Liver Neoplasms; D009369:Neoplasms / Q000453:epidemiology*; D009447:Neuroblastoma; D012509:Sarcoma; D014116:Toxicology; D014508:Urea
D000970:Antineoplastic Agents; D014508:Urea; D006918:Hydroxyurea
ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; CARCINOMA, EPIDERMOID; CARCINOMA, TRANSITIONAL CELL; DRUG THERAPY; HEPATOMA; LEUKOPENIA; NEOPLASM STATISTICS; NEUROBLASTOMA; SARCOMA; TOXICOLOGIC REPORT; UREA